The Cloning, Protein Production, Crystallization, and X-ray Data Collection Core constitute a distributed pipeline for X-ray crystal structure determination. The distributed structure takes advantage of local expertise, with the cloning facility at Texas A&M University, the protein purification facility at Los Alamos National Labs, the crystallization facility at Lawrence Livermore National Laboratory, the nanocrystallization facility at UC Berkeley and the X-ray data collection and analysis core located at the Advanced Light Source. This core group is responsible for the majority of the cloning, purification, crystallization and data collection with the program project. The overall goal of this group of core laboratories is to: 1) provide a rapid access library of expressible clones for structural, biochemical and genetic studies, 2) provide highly purified target proteins with sufficient quantity for structure determination through standardization, automation, and parallelization of protocols 3) conduct crystal screens for crystal studies 4) provide screening solutions for inhibitor screens, 5) collect high-resolution MAD data to solve 30-40 structures per year. The pipeline facilities are capable of conducting large-scale clone preparation using a modified Gateway cloning system (Invitrogen) that incorporates a cleavable fusion tag into the system and allows for expression in both E. coli and M. smegmatis. The protein production facility has the capacity to produce 6-8 highly purified target proteins per week using high yield auto-inducing fermentation, parallel cell lysis, parallel affinity and gel filtration chromatography. The crystallization facility currently has the peak capability to prepare 3000 crystallization experiments daily, which is sufficient to screen 8 proteins per day. Some high value targets cannot be produced in quantities sufficient for standard processing and will be screened for crystallization at the UCB nanocrystallization facility. The UCB nano-crystallization facility has developed the infrastructure to screen 384 conditions each for as many as 100 proteins annually using the Fluidigm screening chips. The screening chip requires <2uL of protein per 96 experiments. The X-ray facility has 2 days per month pre-scheduled beam time at the Advanced Light Source (ALS). This time is sufficient to screen crystals and collect MAD data for the determination of up to 30-40 de novo structures per year. The core labs described in this proposal are essential for the successful completion of the overall goals of this program project.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI068135-04
Application #
7780415
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2009-04-01
Budget End
2010-03-31
Support Year
4
Fiscal Year
2009
Total Cost
$916,735
Indirect Cost
Name
Texas Agrilife Research
Department
Type
DUNS #
847205713
City
College Station
State
TX
Country
United States
Zip Code
77843
Tuukkanen, Anne T; Freire, Diana; Chan, Sum et al. (2018) Structural Variability of EspG Chaperones from Mycobacterial ESX-1, ESX-3, and ESX-5 Type VII Secretion Systems. J Mol Biol :
Prigozhin, Daniil M; Papavinasasundaram, Kadamba G; Baer, Christina E et al. (2016) Structural and Genetic Analyses of the Mycobacterium tuberculosis Protein Kinase B Sensor Domain Identify a Potential Ligand-binding Site. J Biol Chem 291:22961-22969
Wagner, Jonathan M; Chan, Sum; Evans, Timothy J et al. (2016) Structures of EccB1 and EccD1 from the core complex of the mycobacterial ESX-1 type VII secretion system. BMC Struct Biol 16:5
DeJesus, Michael A; Zhang, Yanjia J; Sassetti, Christopher M et al. (2013) Bayesian analysis of gene essentiality based on sequencing of transposon insertion libraries. Bioinformatics 29:695-703
Liu, Zhen; Ioerger, Thomas R; Wang, Feng et al. (2013) Structures of Mycobacterium tuberculosis FadD10 protein reveal a new type of adenylate-forming enzyme. J Biol Chem 288:18473-83
Ioerger, Thomas R; O'Malley, Theresa; Liao, Reiling et al. (2013) Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosis. PLoS One 8:e75245
Miallau, Linda; Jain, Paras; Arbing, Mark A et al. (2013) Comparative proteomics identifies the cell-associated lethality of M. tuberculosis RelBE-like toxin-antitoxin complexes. Structure 21:627-37
Tretter, Elsa M; Berger, James M (2012) Mechanisms for defining supercoiling set point of DNA gyrase orthologs: II. The shape of the GyrA subunit C-terminal domain (CTD) is not a sole determinant for controlling supercoiling efficiency. J Biol Chem 287:18645-54
Chim, Nicholas; Owens, Cedric P; Contreras, Heidi et al. (2012) Advances In Mycobacterium Tuberculosis Therapeutics Discovery Utlizing Structural Biology. Infect Disord Drug Targets :
Cavazos, Alexandra; Prigozhin, Daniil M; Alber, Tom (2012) Structure of the sensor domain of Mycobacterium tuberculosis PknH receptor kinase reveals a conserved binding cleft. J Mol Biol 422:488-94

Showing the most recent 10 out of 51 publications